GLP-1 weight loss injections at a med spa: what patients need to know
Semaglutide and tirzepatide are prescription medications that require clinical oversight. Here's what to look for in a provider, what the process should actually involve, and what to ask before you sign up.
· By MedSpot Editorial · 4 min read
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and compounded alternatives — have become one of the most requested services at medical spas and weight management clinics. With that demand has come a wide range in provider quality: practices doing this right, and practices doing it in ways that put patients at risk. Here's how to tell the difference.
What GLP-1 medications actually do
GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a hormone released after eating. They:
- Slow gastric emptying — food moves through the stomach more slowly, producing prolonged fullness
- Reduce appetite — act on hypothalamic receptors to reduce hunger signals
- Lower blood glucose — originally developed for type 2 diabetes management (hence Ozempic)
- Promote weight loss — clinical trials show 10–22% body weight reduction over 68 weeks for semaglutide; similar or greater for tirzepatide
These are prescription medications. They are not supplements, wellness shots, or aesthetic treatments — they are drugs with real mechanisms and real side effects that require clinical monitoring.
Branded vs. compounded GLP-1
The FDA-approved branded medications (Ozempic, Wegovy, Mounjaro, Zepbound) are manufactured under strict quality standards. During the shortage period that began in 2022, compounding pharmacies have produced alternative formulations:
- Compounded semaglutide — not FDA-approved but legal during shortage periods; quality varies significantly by pharmacy
- Compounded tirzepatide — same situation; compound pharmacies must be 503A or 503B facilities in good standing
What to ask: "Which formulation do you use, and from which pharmacy? What is that pharmacy's accreditation status?"
A legitimate provider can answer this immediately. Vague answers ("our proprietary blend," "pharmaceutical grade") are red flags.
What proper clinical oversight looks like
This is where med spas vary most. A responsible GLP-1 protocol includes:
At intake:
- Body weight, height, BMI
- Medical history review — contraindications include personal/family history of medullary thyroid carcinoma or MEN2 syndrome, pancreatitis history
- Basic labs (at minimum: HbA1c, fasting glucose, lipid panel, comprehensive metabolic panel, thyroid panel)
- Blood pressure assessment
- Current medications review (GLP-1s interact with other diabetes medications)
- Discussion of realistic expectations and side effects
During treatment:
- Monthly (or at minimum quarterly) check-ins
- Lab monitoring as indicated
- Side-effect management guidance (nausea, vomiting, and constipation are common in the first 4–8 weeks; there are protocols to manage these)
- Dose escalation supervised by a clinician
A practice that prescribes GLP-1 medications after a 10-minute intake form with no labs is not practicing safely.
Side effects to know
Common (first 4–12 weeks, often improving over time):
- Nausea (most common; 20–44% in trials)
- Vomiting
- Constipation or diarrhea
- Fatigue
- Injection site reactions
Less common but serious:
- Pancreatitis — stop medication and seek care if you develop severe abdominal pain radiating to your back
- Gallstones — rapid weight loss increases risk; abdominal pain after fatty meals should be evaluated
- Gastroparesis — severely slowed gastric emptying; can occur with extended use
- Muscle loss — weight loss on GLP-1s includes some muscle mass; resistance training and adequate protein (1.2–1.6g/kg) significantly mitigate this
What "Ozempic face" actually means
"Ozempic face" refers to facial hollowing and volume loss that some patients experience with significant weight loss on GLP-1s. This is not a drug-specific side effect — it's a consequence of rapid weight loss from any cause. Fat redistributes from the face along with the rest of the body.
Patients on GLP-1s who experience facial volume loss may benefit from filler consultations once their weight stabilizes. This is one reason med spas offering both GLP-1 programs and injectables are positioned to provide comprehensive care — though it shouldn't be the primary reason you choose a provider.
Questions to ask before starting
- "What labs do you require before prescribing?"
- "Which formulation do you use, and from which compounding pharmacy?"
- "Who is the supervising prescriber, and what are their credentials?"
- "What's the check-in schedule during treatment?"
- "What do I do if I experience significant side effects?"
- "Is this compounded or branded medication?"
A practice that can't answer all of these questions clearly should not be managing your medication.
Looking for a weight management provider? Browse wellness providers on MedSpot and check profiles for clinical credentials and GLP-1 program details.